GTS Securities’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
+41,061
New +$2.08M 0.04% 251
2026
Q1
Sell
-50,031
Closed -$3.11M 1658
2025
Q4
$3.11M Buy
50,031
+36,003
+257% +$2.22M 0.11% 136
2025
Q3
$843K Sell
14,028
-123,714
-90% -$7.57M 0.03% 495
2025
Q2
$8.63M Buy
137,742
+118,754
+625% +$7.14M 0.38% 43
2025
Q1
$1.14M Buy
18,988
+12,296
+184% +$764K 0.05% 338
2024
Q4
$390K Sell
6,692
-7,972
-54% -$474K 0.02% 722
2024
Q3
$868K Sell
14,664
-24,833
-63% -$1.42M ﹤0.01% 2277
2024
Q2
$2.21M Buy
39,497
+16,901
+75% +$946K ﹤0.01% 1424
2024
Q1
$1.32M Buy
+22,596
New +$1.28M ﹤0.01% 1780
2023
Q4
Sell
-34,706
Closed -$1.7M 4203
2023
Q3
$1.68M Buy
34,706
+28,309
+443% +$1.51M ﹤0.01% 1643
2023
Q2
$361K Buy
+6,397
New +$352K 0.01% 796

Other funds holding IHI

GTS Securities's IHI Position: Q2 2026 in Review

GTS Securities opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 41,061 shares worth $2.03M. The stake represents 0.04% of the portfolio and ranks #251 among its holdings. This is a return to the name: GTS Securities previously reported a position in IHI as recently as Q4 2025.

GTS Securities first reported a position in IHI in Q2 2023 and has held it in 11 quarters since. The position peaked at $8.63M in Q2 2025. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • GTS Securities held 41,061 shares of iShares US Medical Devices ETF worth $2.03M as of Q2 2026.
  • iShares US Medical Devices ETF was a new GTS Securities position in Q2 2026.
  • iShares US Medical Devices ETF made up 0.04% of GTS Securities's portfolio in Q2 2026, its #251 holding.
  • GTS Securities first reported a position in iShares US Medical Devices ETF in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's iShares US Medical Devices ETF position peaked at $8.63M in Q2 2025.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.